Central Pharmaceutical JSC No3
VN:DP3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Central Pharmaceutical JSC No3
VN:DP3
|
VN |
|
H
|
Hindustan Foods Ltd
NSE:HNDFDS
|
IN |
|
A
|
Ameriprise Financial Inc
F:A4S
|
US |
|
Crown Castle International Corp
NYSE:CCI
|
US |
|
M
|
Moody's Corp
XBER:DUT
|
US |
|
P
|
Paychex Inc
DUS:PCX
|
US |
|
Aptiv PLC
NYSE:APTV
|
IE |
|
V
|
Vertex Pharmaceuticals Inc
BMV:VRTX
|
US |
|
T
|
Tokyo Electron Ltd
DUS:TKY
|
JP |
|
H
|
Halma PLC
F:H11
|
UK |
|
K
|
Kering SA
SWB:PPX
|
FR |
|
F
|
First Advantage Corp
XBER:0MS
|
US |
|
T
|
Tesco PLC
OTC:TSCDF
|
UK |
|
HKScan Oyj
F:HK4
|
FI |
|
R
|
Real Estate 11 JSC
VN:D11
|
VN |
Wall St Price Targets
DP3 Price Targets Summary
Central Pharmaceutical JSC No3
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DP3's stock price target?
Not Available
DP3 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Central Pharmaceutical JSC No3?
Projected CAGR
-100%
Over the last 10 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 1 year is -100%.